JPRN-UMIN000004492
Completed
未知
Clinical trial aimed at new therapeutic approch against HAM patients by pentosan polysulphate - Clinical trial against HAM patients by pentosan polysulphate
Department of Molecular Microbilogy and Immunology0 sites15 target enrollmentNovember 1, 2010
ConditionsHTLV-I associated myelopathy (HAM)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HTLV-I associated myelopathy (HAM)
- Sponsor
- Department of Molecular Microbilogy and Immunology
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients who both prothrombin time and activated partial thromboplastin time are more than normal ranges at screening test
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical trial aimed at new therapeutic strategy for HAM by prosultiamine treatment with oral administratioHTLV-I associated myelopathy (HAM)JPRN-UMIN000005969The Department of Molecular Microbiology and Immunology25
Active, not recruiting
Phase 2
Study on efficacy of herbal drugs in reducing viral load in HIV/AIDS patientsCTRI/2022/09/045548MVR Ayurveda medical college
Recruiting
Phase 3
Thalidomide effects in COVID-19Covid 19.Covid 19IRCT20110423006257N3Arak University of Medical Sciences66
Active, not recruiting
Not Applicable
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKactinic keratosisMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
Active, not recruiting
Not Applicable
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15